Alternative splicing as a biomarker and potential target for drug discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Alternative splicing as a biomarker and potential target for drug discovery

Published:2015-06-15 Issue:10 Volume:36 Page:1212-1218
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Le Kai-qin,Prabhakar Bellur S,Hong Wan-jin,Li Liang-cheng

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/aps201543.pdf

Reference40 articles.

1. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008; 456: 470–6.

2. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ . Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 2008; 40: 1413–5.

3. Prokunina-Olsson L, Welch C, Hansson O, Adhikari N, Scott LJ, Usher N, et al. Tissue-specific alternative splicing of TCF7L2. Hum Mol Genet 2009; 18: 3795–804.

4. Zhao S, Chang SL, Linderman JJ, Feng FY, Luker GD . A comprehensive analysis of CXCL12 isoforms in breast cancer. Transl Oncol 2014; May 13. doi: 10.1016/j.tranon.2014.04.001.

5. Biamonti G, Catillo M, Pignataro D, Montecucco A, Ghigna C . The alternative splicing side of cancer. Semin Cell Dev Biol 2014; 32: 30–6.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geneapp: A web application for visualizing alternative splicing for biomedicine;Computers in Biology and Medicine;2024-08

2. The combination of transcriptome and Mendelian randomization reveals clinical and immuno-functional biomarkers of alternative splicing regulation associated with planar cell polarity signaling pathways in pan-cancer;2024-03-28

3. Predicting the Structural Impact of Human Alternative Splicing;2023-12-23

4. Alternative splicing in lung influences COVID-19 severity and respiratory diseases;Nature Communications;2023-10-04

5. Targeting alternative splicing in cancer immunotherapy;Frontiers in Cell and Developmental Biology;2023-08-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3